STINGRAY THERAPEUTICS, INC.

Profile

Company Names

STINGRAY THERAPEUTICS, INC.

Addresses

HEALTH WILDCATTERS INCUBATOR, 3000 PEGASUS PARK DR., SUITE 1330, DALLAS, TX 75247

HEALTH WILDCATTERS INCUBATOR, 3000 PEGASUS PARK DR, SUITE 1330, DALLAS, TX 75247

TMCX - TEXAS MEDICAL CENTER ACCELERATOR, 2450 HOLOCOMBE BLVD EAST, SUITE X, HOUSTON, TX 77021

TMCX-TEXAS MEDICAL CENTER ACCELERATOR, 2450 HOLCOMBE BLVD, SUITE X, HOUSTON, TX 77021

Phone Numbers

317-517-9500
713-503-7707

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$8,584,110.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-05-01 
$25,000.00 
$5,000,000.00 
$4,975,000.00 
 
3
2023-12-19 
$436,758.00 
$450,000.00 
$13,242.00 
 
2
2023-01-23 
$6,612,080.00 
$6,668,926.00 
$56,846.00 
Equity 
1
2020-07-31 
$1,510,272.00 
$3,000,000.00 
$1,489,728.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
UMA 
 
BHATT 
EXECUTIVE OFFICER, DIRECTOR
SCOTT 
ANDREW 
JORDAN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
JONATHAN 
P. 
NORTHRUP 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
SUNIL 
 
SHARMA 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2024-05-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2023-12-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-01-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-01-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-07-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-07-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-07-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
FINALIS SECURITIES LLC
SCOTT ANDREW JORDAN
NONE
NONE
LIBERI LIFE SCIENCES CONSULTANCY BV
NONE
CIM SECURITIES, LLC
SCOTT ANDREW JORDAN